|
Osimertinib + Chemotherapy Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Tagrisso, Cisplatin, Carboplatin, Pemetrexed
Birmingham, Alabama1 trial
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
University of Alabama at Birmingham
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.